The heat and chills that come with fever are not only uncomfortable but also metabolically costly. Increased body temperature, however, can make all the difference when you’re sick.
Academic rigour, journalistic flair
Articles on Immunology
Displaying 1 - 20 of 91 articles
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
T cells recognize and kill cancer cells but quickly lose their effectiveness. This fast dysfunction may help explain why immunotherapy doesn’t lead to long-term remission for many patients.
We know from other viruses that viral fragments can remain in different tissues for months or even years. This could be the case for long COVID.
Cancer vaccines are an emerging personalised treatment for cancer. Using the same mRNA technology as COVID vaccines, they stimulate the immune system to destroy cancer cells.
Why are Australian black swans so quick to die from bird flu? A new genome study comparing them to their bird brethren helps to unravel the mystery.
An overactive immune response to infection can be deadly. Studying how one key player called tumor necrosis factor, or TNF, induces lethal immune responses could provide new treatment targets.
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.
You might not know you’ve had it. Or perhaps your immune system or genes have given you a boost. Or maybe you’re just lucky.
A new species of bacteria that doesn’t normally live in the gut may trigger an immune response so strong that it spreads to the joints.
On World Rabies Day – which is also the anniversary of French microbiologist Louis Pasteur’s death – a virologist reflects on the achievements of this visionary scientist.
Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
Coinfections with bacteria can make viral infections even deadlier. Researchers have identified a protein in immune cells that may play a role in fighting both types of pathogens.
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.
COVID cases are predicted to rise as we face another variant. So a 4th shot to top up our immunity is looking more likely as we head into winter.
Because COVID-19 is a relatively new virus, researchers still aren’t sure exactly how long vaccines and prior infections provide protection.
COVID-19 has taken away so much. An immunology researcher describes the good it may leave behind.
Top contributors
-
Research Fellow, Institute for Molecular Bioscience, The University of Queensland
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Program Director, Infectious Diseases and Immunology, Menzies Health Institute, Griffith University
-
Instructor of Human Immunology, Emory University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Associate Professor of Viral Immunology, Department of Pathobiology, University of Guelph
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Immunology, RMIT University
-
Laboratory Head, Walter and Eliza Hall Institute
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Associate Professor of Microbiology, Immunology & Pathology, Colorado State University
-
Senior Lecturer; MD, Victoria University
-
Professor of Immunology and Associate Dean, Research and Graduate Studies, University of Guelph
-
Ph.D. Candidate in Chemical & Physical Biology, Vanderbilt Vaccine Center, Vanderbilt University
-
Ph.D. Student in Microbiology and Immunology, Vanderbilt Vaccine Center, Vanderbilt University
